YU46303B - Postupak za proizvodnju prirodnog heparan-sulfata i dermatan-sulfata u suštinski čistom obliku - Google Patents
Postupak za proizvodnju prirodnog heparan-sulfata i dermatan-sulfata u suštinski čistom oblikuInfo
- Publication number
- YU46303B YU46303B YU37586A YU37586A YU46303B YU 46303 B YU46303 B YU 46303B YU 37586 A YU37586 A YU 37586A YU 37586 A YU37586 A YU 37586A YU 46303 B YU46303 B YU 46303B
- Authority
- YU
- Yugoslavia
- Prior art keywords
- solution
- concentration
- weight
- treatment
- urea
- Prior art date
Links
- 229920000045 Dermatan sulfate Polymers 0.000 title abstract 3
- 229920002971 Heparan sulfate Polymers 0.000 title abstract 3
- FPJHWYCPAOPVIV-VOZMEZHOSA-N (2R,3S,4R,5R,6R)-6-[(2R,3R,4R,5R,6R)-5-acetamido-2-(hydroxymethyl)-6-methoxy-3-sulfooxyoxan-4-yl]oxy-4,5-dihydroxy-3-methoxyoxane-2-carboxylic acid Chemical compound CO[C@@H]1O[C@H](CO)[C@H](OS(O)(=O)=O)[C@H](O[C@@H]2O[C@H]([C@@H](OC)[C@H](O)[C@H]2O)C(O)=O)[C@H]1NC(C)=O FPJHWYCPAOPVIV-VOZMEZHOSA-N 0.000 title 1
- 239000000243 solution Substances 0.000 abstract 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 3
- 239000004202 carbamide Substances 0.000 abstract 3
- 238000001914 filtration Methods 0.000 abstract 3
- 238000001556 precipitation Methods 0.000 abstract 3
- 239000011780 sodium chloride Substances 0.000 abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- 229920002683 Glycosaminoglycan Polymers 0.000 abstract 2
- 239000012043 crude product Substances 0.000 abstract 2
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 abstract 2
- 229940051593 dermatan sulfate Drugs 0.000 abstract 2
- 238000010790 dilution Methods 0.000 abstract 2
- 239000012895 dilution Substances 0.000 abstract 2
- 230000008030 elimination Effects 0.000 abstract 2
- 238000003379 elimination reaction Methods 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 238000003756 stirring Methods 0.000 abstract 2
- 102000016611 Proteoglycans Human genes 0.000 abstract 1
- 108010067787 Proteoglycans Proteins 0.000 abstract 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 abstract 1
- 150000001298 alcohols Chemical class 0.000 abstract 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 abstract 1
- 239000000920 calcium hydroxide Substances 0.000 abstract 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 abstract 1
- 125000002091 cationic group Chemical group 0.000 abstract 1
- 238000005352 clarification Methods 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 238000005194 fractionation Methods 0.000 abstract 1
- 150000002576 ketones Chemical class 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 210000004165 myocardium Anatomy 0.000 abstract 1
- 238000006386 neutralization reaction Methods 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 229920005989 resin Polymers 0.000 abstract 1
- 239000011347 resin Substances 0.000 abstract 1
- 239000001632 sodium acetate Substances 0.000 abstract 1
- 235000017281 sodium acetate Nutrition 0.000 abstract 1
- 239000002689 soil Substances 0.000 abstract 1
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical class [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 abstract 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 abstract 1
- 238000000108 ultra-filtration Methods 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0066—Isolation or extraction of proteoglycans from organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
- C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
- C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT8519885A IT1208509B (it) | 1985-03-13 | 1985-03-13 | Processo per la produzione di eparan solfato e dermatan solfato naturali sostanzialmente puri eloro impiego farmaceutico. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| YU37586A YU37586A (en) | 1988-04-30 |
| YU46303B true YU46303B (sh) | 1993-05-28 |
Family
ID=11162062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU37586A YU46303B (sh) | 1985-03-13 | 1986-03-13 | Postupak za proizvodnju prirodnog heparan-sulfata i dermatan-sulfata u suštinski čistom obliku |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4783447A (Sortimente) |
| EP (1) | EP0199033B1 (Sortimente) |
| JP (1) | JPS61218601A (Sortimente) |
| KR (1) | KR910006809B1 (Sortimente) |
| AT (1) | ATE99702T1 (Sortimente) |
| AU (1) | AU582221B2 (Sortimente) |
| CA (1) | CA1286286C (Sortimente) |
| DE (1) | DE3689493T2 (Sortimente) |
| DK (1) | DK113886A (Sortimente) |
| ES (1) | ES8705894A1 (Sortimente) |
| FI (1) | FI82700C (Sortimente) |
| GR (1) | GR860677B (Sortimente) |
| IN (1) | IN163616B (Sortimente) |
| IT (1) | IT1208509B (Sortimente) |
| NO (1) | NO166187C (Sortimente) |
| NZ (1) | NZ215435A (Sortimente) |
| PH (2) | PH22370A (Sortimente) |
| PT (1) | PT82198B (Sortimente) |
| YU (1) | YU46303B (Sortimente) |
| ZA (1) | ZA861855B (Sortimente) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1189085B (it) * | 1986-03-25 | 1988-01-28 | Mediolanum Farmaceutici Srl | Processo per la preparazione di dermatan solfato ad alta purezza e composizioni farmaceutiche che lo contengono |
| US5707604A (en) * | 1986-11-18 | 1998-01-13 | Access Pharmaceuticals, Inc. | Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles |
| DE3639561A1 (de) * | 1986-11-20 | 1988-06-01 | Baumann Hanno | Verfahren zur herstellung von nicht-thrombogenen substraten |
| IT1232939B (it) * | 1987-11-06 | 1992-03-10 | Opocrin Spa | Eparan solfato caratterizzato da elevata attivita' antitrombotica, elevata biodisponibilita', assenza di attivita' anticoagulante; suo processo di estrazione da organi e da tessuti e relative composizioni farmaceutiche |
| WO1989012070A1 (en) * | 1988-06-03 | 1989-12-14 | Italfarmaco S.P.A. | Glycosaminoglycan salts, processes for the preparation thereof and pharmaceutical compositions containing them |
| DE69005251T2 (de) * | 1989-10-04 | 1994-05-05 | Akzo Nv | Sulfatierte Glykosaminoglykuronane mit antithrombotischer Wirkung. |
| EP0493533A4 (en) * | 1989-10-27 | 1992-10-28 | Case Western Reserve University | Inhibition of cell growth by keratan sulfate, chondroitin sulfate, dermatan sulfate and other glycans |
| IT1240615B (it) * | 1990-04-03 | 1993-12-17 | Mediolanum Farmaceutici Spa | Impiego del dermatan solfato nella prevenzione e terapia dell'invecchiamento cerebrale e degli stati di deficit funzionale del sistema nervoso centrale |
| AU7742591A (en) * | 1990-04-06 | 1991-10-30 | Washington University | Anticoagulant oligosaccharides |
| US5705178A (en) * | 1991-05-31 | 1998-01-06 | Gliatech, Inc. | Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| US5605938A (en) * | 1991-05-31 | 1997-02-25 | Gliatech, Inc. | Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
| FR2691066B1 (fr) * | 1992-05-15 | 1995-06-09 | Sanofi Elf | Utilisation de glycosaminoglycanes exogenes, de leurs analogues ainsi que de leurs fragments, fractions et derives, pour la preparation de medicaments destines au traitement de thrombopenies. |
| IT1256236B (it) * | 1992-12-23 | 1995-11-29 | Mediolanum Farmaceutici Srl | Oligosaccaridi aventi attivita' biologica e procedimento per la loro preparazione di glicosaminoglicani |
| PL177218B1 (pl) * | 1993-09-30 | 1999-10-29 | Seikagaku Kogyo Co Ltd | Siarczany dermatanu oraz środki przeciwzakrzepowe zawierające siarczany dermatanu |
| US6106866A (en) * | 1995-07-31 | 2000-08-22 | Access Pharmaceuticals, Inc. | In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites |
| IT1296581B1 (it) * | 1997-11-28 | 1999-07-14 | Istituto Scient Di Chimica E B | Materiali polimerici non trombogenici e ad esaltata compatibilita' con fluidi e tessuti organici |
| AU782661B2 (en) * | 1999-06-30 | 2005-08-18 | Hamilton Civic Hospitals Research Development, Inc. | Heparin compositions that inhibit clot associated coagulation factors |
| HUP0300939A2 (hu) * | 2000-09-08 | 2003-09-29 | Hamilton Civic Hospitals Research Development, Inc. | Antitrombotikus készítmények |
| CN107098989A (zh) * | 2017-04-27 | 2017-08-29 | 甘肃省金羚集团药业有限公司 | 一种肝素钠的制备方法 |
| CN114478832B (zh) * | 2022-02-14 | 2023-03-03 | 河北常山生化药业股份有限公司 | 从肝素钠副产物中提纯四种多糖类产品的方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3179566A (en) * | 1963-05-16 | 1965-04-20 | Canada Packers Ltd | Purification of heparin |
| JPS5318520B2 (Sortimente) * | 1972-07-05 | 1978-06-15 | ||
| AR207237A1 (es) * | 1974-02-25 | 1976-09-22 | Thomas A | Procedimiento para obtener extractos biologicos estables liofilizados solubles constituidos por complejos proteicos termorresistentes |
| US4243582A (en) * | 1979-04-26 | 1981-01-06 | Monsanto Company | Novel glycoproteins from bovine cartilage |
| JPS58171403A (ja) * | 1982-04-01 | 1983-10-08 | Eisai Co Ltd | ヘパラン硫酸の精製法 |
| IT1189298B (it) * | 1982-06-18 | 1988-02-04 | Manetti & Roberts Italo Brit | Procedimento per produrre i glicosa minoglicani dermatansolfato ed eparan-solfato sostanzialmente puri e loro impiego farmaceutico |
| FR2555993B1 (fr) * | 1983-12-06 | 1986-11-07 | Anic Spa | Chitosanes 6-sulfates et procede pour leur preparation |
| IT1195497B (it) * | 1983-03-08 | 1988-10-19 | Opocrin Spa | Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina |
| IT1163772B (it) * | 1983-07-13 | 1987-04-08 | Baldacci Lab Spa | Oligosaccaridi eterogenei complessabili ed alfa-idosani ad attivita' terapeutica, procedimento per la loro preparazione e relative composizioni farmaceutiche |
-
1985
- 1985-03-13 IT IT8519885A patent/IT1208509B/it active
-
1986
- 1986-03-06 AT AT86102963T patent/ATE99702T1/de not_active IP Right Cessation
- 1986-03-06 EP EP86102963A patent/EP0199033B1/en not_active Expired - Lifetime
- 1986-03-06 DE DE86102963T patent/DE3689493T2/de not_active Expired - Fee Related
- 1986-03-10 US US06/838,133 patent/US4783447A/en not_active Expired - Fee Related
- 1986-03-11 NZ NZ215435A patent/NZ215435A/xx unknown
- 1986-03-12 GR GR860677A patent/GR860677B/el unknown
- 1986-03-12 ZA ZA861855A patent/ZA861855B/xx unknown
- 1986-03-12 PH PH33516A patent/PH22370A/en unknown
- 1986-03-12 NO NO860940A patent/NO166187C/no unknown
- 1986-03-12 ES ES552898A patent/ES8705894A1/es not_active Expired
- 1986-03-12 IN IN184/CAL/86A patent/IN163616B/en unknown
- 1986-03-12 CA CA000503943A patent/CA1286286C/en not_active Expired - Lifetime
- 1986-03-12 DK DK113886A patent/DK113886A/da not_active Application Discontinuation
- 1986-03-12 FI FI861020A patent/FI82700C/fi not_active IP Right Cessation
- 1986-03-13 JP JP61053838A patent/JPS61218601A/ja active Granted
- 1986-03-13 KR KR1019860001805A patent/KR910006809B1/ko not_active Expired
- 1986-03-13 YU YU37586A patent/YU46303B/sh unknown
- 1986-03-13 AU AU54727/86A patent/AU582221B2/en not_active Ceased
- 1986-03-13 PT PT82198A patent/PT82198B/pt unknown
-
1987
- 1987-06-10 PH PH35381A patent/PH25136A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU46303B (sh) | Postupak za proizvodnju prirodnog heparan-sulfata i dermatan-sulfata u suštinski čistom obliku | |
| DE3689380T2 (de) | Chemische Derivate von GHL-Cu. | |
| US5126135A (en) | Dermatological composition based on an aqueous phase | |
| ES2307540T3 (es) | Uso de fucoidano como ingrediente eficaz para la restauracion del pelo. | |
| IT1200947B (it) | Soluzione acquosa o acquosa-alcoli-ca acida di un sale di chitosano,da impiegare in composizioni cosmetiche | |
| DE2433407A1 (de) | Sulfate von hydroxyaethylstaerke | |
| WO2012032364A1 (en) | Stabilized solution of ortho-silicic acid based on salicylic acid as effective inhibitor of its polymerization, its preparation and use | |
| JPS54160740A (en) | Anti-fibrotic agent | |
| ES2060012T5 (es) | Polidextrosa modificada y procedimiento para su preparacion. | |
| EP0539627B1 (en) | A process for the purification of commercial carrageenins | |
| EP0097625A2 (en) | Process for producing substantially pure dermatan sulfate and heparan sulfate glycosaminoglycans, and pharmaceutical use thereof | |
| DE2618146A1 (de) | Extraktionsverfahren fuer eine suesse substanz | |
| DE3684868D1 (de) | Verwendung von pflanzenpollenextrakten zur herstellung von das wachstum von tumorzellen hemmenden pharmazeutischen praeparaten und verfahren zu ihrer herstellung. | |
| DE69104988T2 (de) | Mikrokapseln mit wänden aus mischungen von durch bivalenten kationen koagulierten atelokollogen und polyholosiden. | |
| KR850700008A (ko) | 의약용과 미용에 사용되는 조성물의 제조방법 | |
| GB1018528A (en) | New physiologically active protein fractions from mistletoe and process for their preparation | |
| DE2447050C2 (de) | Verfahren zur Gewinnung von Proteasenhemmstoff | |
| US3751564A (en) | Process for preparing scleroprotein-alkyl thiosulfate agents for the care of the hair | |
| EP0107846A1 (de) | Mittel zur Pflege oder Behandlung der menschlichen Haut | |
| Wasner et al. | Die chemische struktur der biosynthetischen vorstufe des squalens | |
| ES2118653T3 (es) | Proceso para la preparacion de soluciones acuosas fluidas de alta concentracion de betainas. | |
| PT1219615E (pt) | Método para extrair misturas de flavonas e utilização das misturas que desta forma se obtiveram em produtos dermocosméticos, alimentares e farmacêuticos. | |
| DE1617766C (de) | Verfahren zur Herstellung von Poly peptidpraparaten mit kallikrein und trypsinhemmender Wirkung | |
| US2871236A (en) | Polyuronic acid choline-metal salts | |
| KR20040056495A (ko) | 산소를 함유한 화장품제조방법 |